• Nie Znaleziono Wyników

Endovascular management of heavily calcified abdominal aorta dissection during transcatheter aortic valve implantation

N/A
N/A
Protected

Academic year: 2022

Share "Endovascular management of heavily calcified abdominal aorta dissection during transcatheter aortic valve implantation"

Copied!
2
0
0

Pełen tekst

(1)

Address for correspondence: Panagiotis Antiochos, MD, Division of Cardiology, University Hospital of Lausanne, Rue du Bugnon 46, CH-1011 Lausanne, Switzerland, e-mail: panagiotis.antiochos@chuv.ch

Received: 11.09.2016 Accepted: 03.10.2016

Endovascular management of heavily calcified abdominal aorta dissection during transcatheter

aortic valve implantation

Panagiotis Antiochos

1

, Pierre Monney

1

, Stephane Fournier

1

, Christan Roguelov

1

, Salah D. Qanadli

2

, Eric Eeckhout

1

, Olivier Muller

1

1Department of Internal Medicine, Division of Cardiology, University Hospital of Lausanne, Switzerland

2Department of Radiology, University Hospital of Lausanne, Switzerland

An 82-year-old woman known for diabetes mellitus, chronic kidney disease, porcelain aorta, and previous mitral valve replacement was ad- mitted for transcatheter aortic valve implantation

Figure 1. A. Before transcatheter aortic valve implantation (TAVI): abdominal aorta with extensive circumferential calcifications; B, C. After TAVI: fracture and vertical displacement of abdominal aorta wall with bilateral dissection traces; D, E. Transfemoral implantation of a covered metal stent across the fracture site and successful restoration of the aortic trajectory, without signs of residual dissection; F. Post-procedural computed tomography showing TAV-in- -TAV implantation, transjugular temporary pacemaker lead and stent into the abdominal aorta.

(TAVI). The first aortic prosthesis (Corevalve® 29 mm, Medtronic, MN, USA) was implanted too high above the native aortic annulus, resulting in severe paravalvular regurgitation. TAV-in-TAV

A B C

D E F

655 www.cardiologyjournal.org

interventional cardiology

Cardiology Journal 2016, Vol. 23, No. 6, 655–656

DOI: 10.5603/CJ.2016.0107 Copyright © 2016 Via Medica ISSN 1897–5593

IMAGE IN CARDIOVASCULAR MEDICINE

(2)

implantation (Corevalve® 29 mm) was success- fully performed as a rescue strategy to restore hemodynamics and secure the first valve, with an excellent final result without residual regur- gitation. Multiple passages and manipulation of the valve delivery systems within tortuous peripheral axes resulted in a fluoroscopically vis- ible vertical displacement of the heavily calcified abdominal aorta (Fig. 1A, B). Contrast aortogra- phy ruled out active bleeding and showed traces of bilateral dissection in the abdominal aorta wall (Fig. 1C; Supplementary Video 1 — see journal website). Using the same transfemo- ral access, a 13.5 × 60 mm covered stent graft (Fluency® Plus Endovascular Stent Graft, Bard, AZ, USA) was successfully implanted across the dissection site (Fig. 1D), sealing dissection

traces and restoring alignment of the abdominal aorta (Fig. E, F; Supplementary Video 2 — see journal website). The patient had an unevent- ful recovery and was eventually discharged to cardiac rehabilitation.

This is — to the best of our knowledge — the first case of endovascular treatment of abdominal aorta dissection during TAVI. Patients at high sur- gical risk, but eligible for TAVI, often present with poor vascular anatomy, such as the presence of ex- tensive calcifications of the ascending, thoracic or abdominal aorta. Such patients are at higher risk for peripheral vascular complications that can be man- aged percutaneously during the same procedure, in collaboration with interventional radiologists.

Conflict of interest: None declared

656 www.cardiologyjournal.org

Cardiology Journal 2016, Vol. 23, No. 6

Cytaty

Powiązane dokumenty

Early regression of left ventricular mass associated with diastolic improvement after transcatheter aortic valve implantation.. Levy D, Garrison RJ, Savage DD, Kannel WB,

Background: Transaortic (TAo) transcatheter aortic valve implantation (TAVI) is an alter- native approach in patients considered to be at high risk for classical open surgery with poor

Figure 2 Postoperative outcomes of transcarotid and transfemoral transcatheter aortic valve implantation compared between the study groups and with the preoperative values: a –

ence of >48° angle between the aortic annulus Transcatheter aortic valve implantation (TAVI)4. is a well ‑established modern treatment of severe symptomatic

tion in mean (SD) transvalvular gradients after the placement of transcatheter implanted valve in surgical implanted valve of 19.0 (8.8) mm Hg (P <0.001) and a further mean

Figure 1 A – Lotus Edge valve; B – Lotus Edge valve attached to the delivery system; C – angiogram from the procedure showing the valve just before the final locking; D –

Computed tomography showed an aortic annulus area of 293 mm 2 and significant abdominal aortic stenosis with severe calcification (indicated with a yel-.. low

CarnaLife Holo ® (MedApp S.A., Krakow, Poland) visualises the individual patient’s heart as an interactive holographic image based on computed tomography (CT) or a